Thermo Fisher Scientific
Shardul Sampat currently serves as the Sr. Director of Strategic Pricing & Deal Desk at Thermo Fisher Scientific, a position held since August 2025. Prior to this role, Shardul was the Global Director of Pricing Strategy, Market Insights, and Commercial Analytics at embecta, formerly Becton Dickinson Diabetes Care, from October 2019 to August 2025. Shardul's professional background includes significant positions at Medtronic Diabetes, BD, Johnson & Johnson, Xerox, and PricewaterhouseCoopers, with a focus on business planning, pricing strategy, and financial analysis. Shardul holds a Bachelor of Science in Finance from The University of Texas at Dallas and an Executive Certification in Leading Operational Excellence from MIT Sloan School of Management.
This person is not in any teams
This person is not in any offices
Thermo Fisher Scientific
222 followers
Thermo Fisher Scientific is an American multinational biotechnology product development company, created in 2006 by the merger of Thermo Electron and Fisher Scientific.